| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-17 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.25 | 6e-15 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-14 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-13 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-13 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.24 | 8e-13 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |